The frequency of fibromyalgia in familial Mediterranean fever and its impact on the quality of life
- 18 July 2022
- journal article
- research article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 25 (10) , 1123-1128
Abstract
Background and aim Concomitant fibromyalgia syndrome (FMS) has been known to be more frequent in patients with several rheumatic diseases. In this study, our aim was to investigate the prevalence of FMS in patients with familial Mediterranean fever (FMF), to analyze the possible factors related to this frequency, and to evaluate the impact of FMS on the functionality and quality of life (QoL) of the patients with FMF. Patients and methods One hundred cases with FMF and 100 controls were included to this case-control study. FMS coincidence was investigated in all participants according to revised 2016 classification criteria. Demographic features, FMF disease duration, FMF gene mutations, drugs used, attack frequency per year, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and serum fibrinogen levels were recorded. FMF disease severity was assessed by International Severity Scoring System for Familial Mediterranean Fever (ISSF). For the assessments of QoL and functioning, FMF-QoL, Short form 36 (SF-36), and Health Assessment Questionnaire-Disability Index (HAQ-DI) were used, and for the assessment of FMS impact, the fibromyalgia impact questionnaire (FIQ) were used. Results We found an FMS frequency of 33% in patients with FMF in our study using the current FMS classification criteria. This result was significantly higher than in age- and gender-similar controls (6% FMS frequency; P < 0.05). The number of woman patients and FMF disease duration were significantly higher in patients with FMF + FMS than in patients with only FMF (P < 0.001). There was no significant difference in ISSF scores, ESR, CRP, and fibrinogen levels, management regimens, and FMF gene mutation distributions between FMF + FMS and FMF groups. FMF attack frequency was reported as significantly higher in FMF + FMS patients than in others (P < 0.000). In spite of similar FMF-QoL scores, there were significant differences in HAQ-DI and SF-36 scores between groups (P < 0.05). Higher impact of FMS presented negative correlation with functioning and general health, and positive correlation with QoL in FMF + FMS (P < 0.05). Conclusion Concomitant FMS was a common clinical problem in patients with FMF regardless of the severity and characteristics of FMF. The FMS impact may affect function and QoL in patients of FMF. Considerations of the FMS component in the management of FMF may contribute to the holistic approach to FMF.Keywords
This publication has 18 references indexed in Scilit:
- Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF)Annals of the Rheumatic Diseases, 2016
- Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activityRheumatology International, 2014
- A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kinNature Reviews Rheumatology, 2013
- The prevalence of fibromyalgia in patients with Behçet’s disease and its relation with disease activityRheumatology International, 2012
- The validity and reliability of the Turkish version of the Revised Fibromyalgia Impact QuestionnaireClinical Rheumatology, 2010
- Selective Serotonin Reuptake Inhibitors Reduce the Attack Frequency in Familial Mediterranean FeverThe Tohoku Journal of Experimental Medicine, 2007
- Issues in cross‐cultural validity: Example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment QuestionnaireArthritis Care & Research, 2004
- The validity and reliability of the Turkish version of the Fibromyalgia Impact QuestionnaireRheumatology International, 2000
- Criteria for the diagnosis of familial mediterranean feverArthritis & Rheumatism, 1997
- The prevalence and characteristics of fibromyalgia in the general populationArthritis & Rheumatism, 1995